Food News and Research

RSS

Our appetite is dictated by gut bacteria

Bacteria in our stomachs might be deciding when we’ve eaten enough and switch off appetite, according to new research.

2 Dec 2015

Bacteriophage therapy: an alternative to antibiotics? An interview Professor Clokie

A phage is a virus that infects a bacterium. People often get very confused about what the difference is between a virus and a bacterium. A virus, like a bacterium, is also a microorganism, but unlike bacteria, it needs to have a host to be able to replicate and propagate.

2 Dec 2015

Vanderbilt's Jessica Bennett offers 10 tips for avoiding holiday weight gain

Vanderbilt University Medical Center dietitian and certified personal trainer Jessica Bennett is asked frequently this time of year: how can I enjoy holiday parties and meals with family and not gain weight.

1 Dec 2015

The Importance of Flexibility in Spectrophotometry

News-Medical speaks to Jessica Geisler about the need for flexible spectrophotometers that can handle a range of measurement types.

From Eppendorf 1 Dec 2015

Combination of antiviral medications can eradicate HCV infection in patients with advanced liver disease

A large multi-center clinical trial has found that a combination of antiviral medications can eradicate hepatitis C infection in more than 90 percent of patients with advanced liver disease. Known as the ASTRAL-4 trial, the study was co-led by investigators at Beth Israel Deaconess Medical Center and Intermountain Medical Center and published online Nov. 17 in The New England Journal of Medicine.

1 Dec 2015

Boston Scientific obtains FDA approval, CE Mark for AngioJet ZelanteDVT catheter to treat DVT

Boston Scientific has received United States (U.S.) Food and Drug Administration approval and CE Mark for the AngioJet ZelanteDVT thrombectomy catheter to treat deep vein thrombosis (DVT) in large-diameter upper and lower limb peripheral veins.

30 Nov 2015

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications.

30 Nov 2015

UVA opens clinical trial to examine non-surgical treatment for lower urinary tract symptoms

University of Virginia Health System researchers have opened a national clinical trial examining a non-surgical treatment for lower urinary tract symptoms caused by an enlarged prostate.

30 Nov 2015

Korean MFDS approves InSightec's Exablate Neuro system to treat movement, pain and behavioral disorders

Elbit Imaging Ltd. announced today that it was informed by InSightec Ltd., that the Korean Ministry of Food and Drug Safety has approved its Exablate Neuro system to treat movement, pain and behavioral disorders.

30 Nov 2015

Can-Fite BioPharma reports financial results, provides updates on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the nine months ended September 30, 2015 and updates on its drug development programs.

27 Nov 2015

Survey: More than 1 in 4 middle-aged Indians on low and middling incomes carry unhealthy midriff bulge

More than one in four middle-aged Indians on low and middling incomes now has an unhealthy midriff bulge, with women most likely to carry a spare tyre, reveal the results of a nationally representative survey, published in the online journal BMJ Open.

27 Nov 2015

E. coli can move faster and farther in syrup-like fluids than in water, say Penn researchers

Swimming in a pool of syrup would be difficult for most people, but for bacteria like E. coli, it's easier than swimming in water. Scientists have known for decades that these cells move faster and farther in viscoelastic fluids, such as the saliva, mucus, and other bodily fluids they are likely to call home, but didn't understand why.

26 Nov 2015

Green Cross' GCFlu Quadrivalent approved to protect against four influenza strains in South Korea

Green Cross Corporation, a South Korean biopharmaceutical company, announced today that South Korea's Ministry of Food and Drug Safety has approved GCFLU QUADRIVALENT (Influenza Virus Vaccine) for immunisation of adults to help prevent disease caused by seasonal influenza (flu) virus subtype A and B. GCFlu Quadrivalent is the first locally-manufactured vaccine to cover against four influenza strains.

26 Nov 2015

New drug combination shows promise in treating men with metastatic prostate cancer

A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.

26 Nov 2015

Purdue researchers develop products and processes to improve detection, treatment of diabetes

Food gatherings at Thanksgiving and Christmas require rigorous management by people affected by diabetes. Type 1 diabetes, also known as juvenile diabetes, is the result of the breakdown of insulin-producing cells in the pancreas. Type 2 diabetes can be the result of a combination of obesity, high caloric intake and a sedentary lifestyle.

26 Nov 2015

Universal uptake of Health Star Rating system crucial in combating childhood obesity

Cancer Council Queensland is calling on Government and food manufacturers to use the Health Star Rating system as a tool for combatting childhood overweight and obesity.

26 Nov 2015

Seqirus announces FDA approval of Fluad for seasonal influenza

Seqirus announced today that the US Food and Drug Administration has approved Fluad (Influenza Vaccine, Adjuvanted) to help protect those aged 65 years and older against seasonal influenza. Fluad is the first adjuvanted seasonal influenza vaccine approved in the United States; it was specifically developed for the adult population aged 65 and older.

25 Nov 2015

BioLight signs joint financing agreement with two Asia-based venture capital firms

BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.

25 Nov 2015

Run-and-scan strategy more efficient than tracking strategy in finding target

It's dinnertime, and the smell of delicious food makes your tummy rumble. However, it's dark because of a powercut and you can't see very clearly. Should you try to 'follow your nose' to locate food? Or should you simply guess and peek into the kitchen, or the dining room or the veranda - the likeliest places for dinner to be served? A recent study shows that the latter method - dubbed 'run-and-scan' - may actually be more efficient in finding your target than just following your nose.

25 Nov 2015

Physical exercise can enhance development of new brain cells

Exercise can enhance the development of new brain cells in the adult brain, a process called adult neurogenesis. These newborn brain cells play an important role in learning and memory. A new study has determined that mice that spent time running on wheels not only developed twice the normal number of new neurons, but also showed an increased ability to distinguish new objects from familiar objects.

25 Nov 2015

Food News and Research

Our appetite is dictated by gut bacteria

Bacteriophage therapy: an alternative to antibiotics? An interview Professor Clokie

Vanderbilt's Jessica Bennett offers 10 tips for avoiding holiday weight gain

The Importance of Flexibility in Spectrophotometry

Combination of antiviral medications can eradicate HCV infection in patients with advanced liver disease

Boston Scientific obtains FDA approval, CE Mark for AngioJet ZelanteDVT catheter to treat DVT

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

UVA opens clinical trial to examine non-surgical treatment for lower urinary tract symptoms

Korean MFDS approves InSightec's Exablate Neuro system to treat movement, pain and behavioral disorders

Can-Fite BioPharma reports financial results, provides updates on drug development programs

Survey: More than 1 in 4 middle-aged Indians on low and middling incomes carry unhealthy midriff bulge

E. coli can move faster and farther in syrup-like fluids than in water, say Penn researchers

Green Cross' GCFlu Quadrivalent approved to protect against four influenza strains in South Korea

New drug combination shows promise in treating men with metastatic prostate cancer

Purdue researchers develop products and processes to improve detection, treatment of diabetes

Universal uptake of Health Star Rating system crucial in combating childhood obesity

Seqirus announces FDA approval of Fluad for seasonal influenza

BioLight signs joint financing agreement with two Asia-based venture capital firms

Run-and-scan strategy more efficient than tracking strategy in finding target

Physical exercise can enhance development of new brain cells

The future is bioengineered: Synthetic biology and global sustainability eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News